AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+0.46%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$4.11B
AUM Growth
+$4.11B
(+1.7%)
Cap. Flow
+$109M
Cap. Flow
% of AUM
2.65%
Top 10 Holdings %
Top 10 Hldgs %
28.69%
Holding
188
New
51
Increased
37
Reduced
34
Closed
43
Top Buys
| 1 |
AutoZone
AZO
|
$79.7M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$70.6M |
| 3 |
Ulta Beauty
ULTA
|
$62.1M |
| 4 |
TJX Companies
TJX
|
$52.9M |
| 5 |
Crocs
CROX
|
$50.8M |
Top Sells
| 1 |
Five Below
FIVE
|
$67.4M |
| 2 |
PTC Therapeutics
PTCT
|
$66.9M |
| 3 |
Burlington
BURL
|
$60.4M |
| 4 |
Enanta Pharmaceuticals
ENTA
|
$58.3M |
| 5 |
Ross Stores
ROST
|
$42.3M |
Sector Composition
| 1 | Healthcare | 63.39% |
| 2 | Consumer Discretionary | 11.67% |
| 3 | Consumer Staples | 10.8% |
| 4 | Technology | 8.86% |
| 5 | Communication Services | 2.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Incyte
INCY
$16.5B
| $158M | 2.59% | 2,156,000 -216,000 | -9% | -$15.9M |
|
2
Bristol-Myers Squibb
BMY
$96B
| $145M | 2.37% | 2,324,000 -32,000 | -1% | -$2M |
|
3
Travere Therapeutics
TVTX
$1.56B
| $127M | 2.07% | 4,078,000 -670,000 | -14% | -$20.8M |
|
|
MRTX
4
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $123M | 2.01% | 836,000 +126,000 | +18% | +$18.5M |
|
5
Supernus Pharmaceuticals
SUPN
$2.53B
| $121M | 1.97% | 4,136,000 +236,000 | +6% | +$6.88M |
|
|
6
Jazz Pharmaceuticals
JAZZ
$7.75B
| $112M | 1.83% | 878,000 +554,000 | +171% | +$70.6M |
|
7
Biogen
BIIB
$19.4B
| $110M | 1.81% | 460,000 +88,000 | +24% | +$21.1M |
|
8
Vertex Pharmaceuticals
VRTX
$100B
| $107M | 1.75% | 488,000 -148,000 | -23% | -$32.5M |
|
9
Madrigal Pharmaceuticals
MDGL
$9.76B
| $95.2M | 1.56% | 1,124,000 +88,000 | +8% | +$7.46M |
|
10
Walmart
WMT
$774B
| $82.6M | 1.35% | 570,618 +200,275 | +54% | +$29M |
|
|
11
AutoZone
AZO
$70.2B
| $79.7M | 1.3% | +38,024 | New | +$79.7M |
|
|
12
Enanta Pharmaceuticals
ENTA
$180M
| $79M | 1.29% | 1,056,000 -780,000 | -42% | -$58.3M |
|
13
Pacira BioSciences
PCRX
$1.2B
| $78.9M | 1.29% | 1,312,000 +376,000 | +40% | +$22.6M |
|
14
Avalo Therapeutics
AVTX
$122M
| $76.5M | 1.25% | 45,000,000 | – | – |
|
15
Alkermes
ALKS
$4.78B
| $73.8M | 1.21% | 3,172,000 +816,000 | +35% | +$19M |
|
16
Medtronic
MDT
$119B
| $73.7M | 1.21% | 712,000 +262,000 | +58% | +$27.1M |
|
17
Regeneron Pharmaceuticals
REGN
$61.5B
| $73.3M | 1.2% | 116,000 +16,000 | +16% | +$10.1M |
|
18
CRISPR Therapeutics
CRSP
$4.71B
| $67.6M | 1.11% | 892,000 +512,000 | +135% | +$38.8M |
|
19
Academy Sports + Outdoors
ASO
$3.56B
| $66.3M | 1.08% | 1,510,086 +114,376 | +8% | +$5.02M |
|
20
argenx
ARGX
$43.6B
| $65.8M | 1.08% | 188,000 -20,000 | -10% | -$7M |
|
21
Catalyst Pharmaceutical
CPRX
$2.52B
| $64.8M | 1.06% | 9,572,000 -428,000 | -4% | -$2.9M |
|
|
BHVN
22
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $64.5M | 1.06% | 468,000 +92,000 | +24% | +$12.7M |
|
|
23
Ulta Beauty
ULTA
$22.1B
| $62.1M | 1.02% | +150,639 | New | +$62.1M |
|
24
Iovance Biotherapeutics
IOVA
$807M
| $57.3M | 0.94% | 3,000,000 -648,000 | -18% | -$12.4M |
|
25
Energizer
ENR
$1.88B
| $55M | 0.9% | 1,372,000 -276,000 | -17% | -$11.1M |
|